Brivanib (BMS-540215) |cas 649735-46-6 |DC Chemicals|Supplier|Price|Buy

DC Chemicals Supply: Brivanib (BMS-540215) ,cas 649735-46-6, Cat No. DC2019, In stock

Contact: website: www.dcchemicals.com,

sales@dcchemicals.com,order@dcchemicals.com,info@dcchemicals.com,

Tel: +86-21-61454686;Fax:+86-21-61642559；

Product name: Brivanib (bms-540215), Synonym:　bms540215, bms 540215, Cat No. DC2019, Cas: 649735-46-6, Chemical Name:(R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[1,2-f][1,2,4]triazin-6-yloxy)propan-2-ol, Molecular Formula: C19H19FN4O3, MW: 370.38

Brivanib (bms-540215) Cas#649735-46-6.Purity:>98%.Best Price and Quality in the Market!Supplied by DC Chemicals! Brivanib is an ATP-competitive inhibitor against human VEGFR2 and FGFR with IC50 of 25 nM and 148 nM, respectively.

Brivanib is the hydrolyzed form of Brivanib alaninate, which is a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus).

For the detailed information about the solubility of Brivanib (bms-540215) in water, the solubility of Brivanib (bms-540215) in DMSO, the solubility of Brivanib (bms-540215) in PBS buffer, the animal experiment of Brivanib (bms-540215),the in vivo and in vitro test of Brivanib (bms-540215),the cell experiment of Brivanib (bms-540215),the IC50 and EC50 of Brivanib (bms-540215)please contact DC Chemicals.